References
Telenius-Berg, M., Berg, B., Hamberger, B., Tibblin, S., Tisell, L.E., Ysander, L., Welander, G.: Impact of screening on prognosis in the multiple endocrine neoplasia type 2 syndromes. Natural history and treatment results in 105 patients. Henry Ford Hosp. Med. J. 32:225, 1984
Vasen, H.F.A., Nieuwenhuijzen Kruseman, A.C., Berkel, H., Beukers, E.K.M. Delprat, C.C., Van Doorn, R.G., Geerdink, R.A., Haak, H.R., Hackeng, W.H.L., Koppeschaar, H.P.J., Krenning, E.P., Lamberts, S.W.J., Lekkerkerker, F.J.F, Michels, R.P.J.: Moers, A.M.J., Pieters, G.F.F.M., Wiersinga, W.M., Lips, C.J.M.: Multiple endocrine neoplasia syndrome type 2: The value of screening and central registration. A study of 15 kindreds in The Netherlands. Am. J. Med. 83:847, 1987
Ponder, B.A.J., Ponder, M.A., Coffey, R., Pembrey, M.E., Gagel, R.F., Telenius-Berg, M., Semple, P., Easton, D.F.: Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet 1:397, 1988
Mulligan, L.M., Kwok, J.B.J., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., Ponder, M.A., Telenius, H., Tunnacliffe, A., Ponder, B.A.J.: Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A). Nature 363:458, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wheeler, M.H. Invited commentary. World J. Surg. 18, 581–582 (1994). https://doi.org/10.1007/BF00353770
Issue Date:
DOI: https://doi.org/10.1007/BF00353770